Morningstar alternatives
Morningstar is built for
US research. European
screening is an afterthought.
Morningstar Investor is one of the most trusted names in investment research — star ratings, analyst reports, and deep US equity coverage. But European small cap screening is thin, the workflow is built around reading reports rather than applying filters, and it costs $34.95/month. If active filter-driven screening is your primary workflow, these alternatives are more efficient.
Updated June 2026 · 5 alternatives reviewed
What a screening-first tool gives you over Morningstar
Filter-driven workflow
Morningstar is built for reading analyst reports and star ratings. ScreenerHero is built for applying filters and getting a ranked table of results — a fundamentally different workflow for active stock discovery.
European coverage that works
Morningstar's European coverage is US-first in practice — small and microcap European names have thin data. ScreenerHero covers all European exchanges including microcaps with consistent fundamental data.
Lower price
Morningstar Investor is $34.95/month. ScreenerHero Pro is €29/month — roughly $6 less, for a tool built entirely around filtering rather than report-reading.
Free core screener
Test the filter depth and European coverage with no account required before paying anything. No trial period — the core screener stays free.
What to look for in a Morningstar alternative
Screener vs. research tool
Is the product built around applying filters to discover stocks, or around reading analyst reports and ratings? These are different workflows and different products.
European small cap coverage
Morningstar's strength is US large caps. Does the alternative have populated fundamental data for European small and microcap names — not just the top 500 European companies?
Filter depth
How many filters can you combine simultaneously, and across which geographies? Morningstar's screener allows basic filtering but is not built for multi-criteria stock discovery.
Output density
Results should be a sortable table with dozens of columns — not a report browser or a card layout with limited columns.
Price relative to workflow
If you rarely read analyst reports, you should not pay for them. Match the subscription cost to what you actually use.
The 5 best Morningstar alternatives for active stock screening (2026)
ScreenerHero
Filter-driven screening. US + Canada + all of Europe. $6 less than Morningstar.
ScreenerHero is built around the screener, not analyst reports. Filter by 40+ fundamental and technical criteria across US, Canadian, and all European equities — including microcaps — and get results in a dense, sortable table you can act on immediately. Pro is €29/month, roughly $6 less than Morningstar Investor, with broader geographic coverage and a free core tier that requires no account.
Markets
US, Canada, BME, Euronext Paris, XETRA, Borsa Italiana — all European exchanges
Screener filters
P/E, P/B, ROE, EV/EBITDA, margins, beta, momentum, dividend yield
UI style
Desktop-first, data-dense, built around the screener
Heatmap
Yes
Finviz
The benchmark for dense US screening — no meaningful European coverage
Finviz is built entirely around the screener — the opposite of Morningstar. Elite at $39.50/month is more expensive than Morningstar Investor but the UX is significantly more efficient for filter-driven screening. Coverage is US-only; European exchanges are not part of the product. The free tier is genuinely useful for US screening.
Markets
US primarily
Screener filters
P/E, P/B, ROE, margins, momentum — US equities only
UI style
Desktop-first, data-dense, screener-first
Heatmap
Yes
Stockopedia
Score-driven research for European equities — expensive, research-oriented
Stockopedia sits in a similar research-oriented segment as Morningstar — it is built around StockRanks composite scores rather than raw filter sliders. The European coverage (UK-weighted, some continental) is stronger than Morningstar. At €60–80/month it is significantly more expensive than ScreenerHero and still does not include Canada.
Markets
UK-weighted, some continental Europe (no Canada)
Screener filters
StockRanks composite (QVM) + custom filters
UI style
Card-based, research-oriented
Heatmap
No
Koyfin
Professional charting and dashboards — screener is secondary
Koyfin Plus is $39/month and built around charting and dashboards rather than research reports. Global fundamental coverage is broader than Morningstar for screening purposes — but the screener is still secondary to the charting infrastructure. European microcap coverage has gaps. Better value than Morningstar for active screeners.
Markets
US + global (large and mid cap focus)
Screener filters
Fundamentals, macroeconomic overlays
UI style
Dashboard-first, chart-oriented
Heatmap
No
TIKR
Broad global coverage, value-investor focus — less dense UI
TIKR attracts a similar value-investor audience to Morningstar, but the product is built around data access rather than analyst ratings. TIKR Plus starts at $10–15/month — significantly cheaper than Morningstar Investor. Pro runs $40–55/month and includes 20-year financial history and earnings transcripts. European microcap coverage is a known gap.
Markets
100k+ stocks, 92 countries
Screener filters
Fundamentals, historical financials, transcripts on Pro
UI style
Data-focused, less dense UI
Heatmap
No
Quick comparison
| ScreenerHero | Morningstar | Finviz | Stockopedia | Koyfin | |
|---|---|---|---|---|---|
| US coverage | |||||
| Canadian coverage | |||||
| European coverage | |||||
| Microcap EU coverage | |||||
| Screener-first UX | |||||
| Dense table UI | |||||
| Heatmap | |||||
| Free core features | |||||
| No account required | |||||
| Price/mo (from) | €29 | $34.95 | $39.50 | €60 | $39 |
Recommendation by use case
You want to actively screen US, Canadian, and European stocks by fundamentals
ScreenerHero — €29/mo, screening-first, free core screener, full EU microcap depth.
You rely on analyst star ratings and written research reports for US equities
Morningstar Investor — the ratings methodology and report quality are unmatched for US large caps. Accept the thin European coverage and report-centric workflow.
You screen US stocks only and want the densest filter experience
Finviz — the benchmark for US screening density. $39.50/month for Elite.
You prefer composite scores and invest primarily in UK and European equities
Stockopedia — well-regarded StockRanks methodology. Accept €60–80/month and coverage limitations.
You want global reach at the lowest price
TIKR Plus — $10–15/month, wide reach, accept European microcap gaps and less dense UI.
$6 less than Morningstar. Built for screening.
Dense tables. Fast filters. Heatmap. US, Canadian, and European equities — including microcaps — in one screening-first tool. Free, no account needed. Pro at €29/month.